Intra-Cellular Therapies Statistics

Total Valuation

HKG:0989 has a market cap or net worth of HKD 234.12 million. The enterprise value is 1.10 billion.

Market Cap	234.12M
Enterprise Value	1.10B

Important Dates

The next estimated earnings date is Thursday, August 28, 2025.

Earnings Date	Aug 28, 2025
Ex-Dividend Date	n/a

Share Statistics

HKG:0989 has 360.18 million shares outstanding.

Current Share Class	360.18M
Shares Outstanding	360.18M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	42.81%
Owned by Institutions (%)	14.44%
Float	205.97M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.17
PB Ratio	-0.35
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-1.21
EV / Sales	5.53
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-24.99

Financial Position

The company has a current ratio of 0.49

Current Ratio	0.49
Quick Ratio	0.02
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-19.81
Interest Coverage	-13.19

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-24.10%
Return on Invested Capital (ROIC)	-51.19%
Return on Capital Employed (ROCE)	112.27%
Revenue Per Employee	1.12M
Profits Per Employee	-5.14M
Employee Count	178
Asset Turnover	0.11
Inventory Turnover	0.85

Taxes

Income Tax	-102.00M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -9.72% in the last 52 weeks. The beta is 2.77, so HKG:0989's price volatility has been higher than the market average.

Beta (5Y)	2.77
52-Week Price Change	-9.72%
50-Day Moving Average	0.79
200-Day Moving Average	0.44
Relative Strength Index (RSI)	45.18
Average Volume (20 Days)	181,535

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:0989 had revenue of HKD 199.79 million and -914.46 million in losses. Loss per share was -2.54.

Revenue	199.79M
Gross Profit	-680.30M
Operating Income	-727.73M
Pretax Income	-1.02B
Net Income	-914.46M
EBITDA	-727.42M
EBIT	-727.73M
Loss Per Share	-2.54

Full Income Statement

Balance Sheet

The company has 5.47 million in cash and 875.53 million in debt, giving a net cash position of -870.06 million or -2.42 per share.

Cash & Cash Equivalents	5.47M
Total Debt	875.53M
Net Cash	-870.06M
Net Cash Per Share	-2.42
Equity (Book Value)	-668.28M
Book Value Per Share	-1.86
Working Capital	-1.01B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -43.58 million and capital expenditures -614,352, giving a free cash flow of -44.19 million.

Operating Cash Flow	-43.58M
Capital Expenditures	-614,352
Free Cash Flow	-44.19M
FCF Per Share	-0.12

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-364.25%
Pretax Margin	-508.77%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

HKG:0989 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-390.60%
FCF Yield	-18.88%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on January 17, 2025. It was a reverse split with a ratio of 0.05.

Last Split Date	Jan 17, 2025
Split Type	Reverse
Split Ratio	0.05

Scores

HKG:0989 has an Altman Z-Score of -5.34 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.34
Piotroski F-Score	2